Firefly Neuroscience
AIFF
9 hedge funds and large institutions have $393K invested in Firefly Neuroscience in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, reducing their positions, and 3 closing their positions.
135% more capital invested
Capital invested by funds: $167K → $393K (+$226K)
0.42% more ownership
Funds ownership: 1.34% → 1.76% (+0.42%)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$299K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$280K |
| 3 |
WPW
Waldron Private Wealth
Bridgeville,
Pennsylvania
|
+$10.5K |
| 4 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$5.04K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TWM
Trueblood Wealth Management
Lima,
Ohio
|
-$33.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $174K | +$280K | +53,472 | +1,376% |
|
|
2
Millennium Management
New York
| $173K | +$299K | +56,934 | New |
|
|
WPW
3
Waldron Private Wealth
Bridgeville,
Pennsylvania
| $36.5K | +$10.5K | +2,000 | +20% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3.96K | +$1.35K | +257 | +25% |
|
|
WC
5
Wexford Capital
West Palm Beach,
Florida
| $2.92K | +$5.04K | +961 | New |
|
6
Wells Fargo
San Francisco,
California
| $2.09K | +$5 | +1 | +0.1% |
|
7
Bank of America
Charlotte,
North Carolina
| $146 | +$231 | +44 | +1,100% |
|
|
CA
8
Continuum Advisory
Eagle,
Idaho
| $73 | +$121 | +23 | New |
|
|
TWM
9
Trueblood Wealth Management
Lima,
Ohio
| – | -$33.1K | -5,333 | Closed |
|
|
10
Vanguard Group
Malvern,
Pennsylvania
| – | -$23K | -3,698 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$14.3K | -2,308 | Closed |
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$79 | +15 | +188% |
|
AIFF Hedge Fund Activity: Q3 2024 in Review
9 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q3 2024, worth a combined $393K — up 135% from $167K a quarter earlier.
Fund positioning in AIFF was balanced in Q3 2024: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $299K. The largest seller was Trueblood Wealth Management, exiting entirely with an estimated $33.1K sold.
- 9 institutional investors held Firefly Neuroscience (AIFF) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $393K of Firefly Neuroscience stock for Q3 2024, up 135% quarter-over-quarter.
- 3 funds opened new Firefly Neuroscience positions in Q3 2024 and 3 closed out, a net change of 0 holders.
- The largest Firefly Neuroscience buyer in Q3 2024 was Millennium Management, an estimated $299K added.
- The largest Firefly Neuroscience seller in Q3 2024 was Trueblood Wealth Management, an estimated $33.1K sold.
Based on aggregated 13F filings for Q3 2024.